STAT3 and rheumatoid arthritis: Network pharmacological analysis predicted the components and mechanisms of ARSHs against RA, screening 15 key components (e.g., dihydrochelerythrine, magnoflorine, etc.)and 24 core targets (e.g., SRC, STAT3, MAPK3, etc.).